In the rapidly evolving TechBio industry, one innovative life sciences company puts technology at the forefront of its approach to drug discovery and experimentation. They operate one of the fastest privately owned supercomputers in the pharmaceutical sector, enabling unprecedented computational scale in biological research. Powered by a bespoke and AI-driven
